On September 8, 2020 Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE:CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address inflammatory, cancer and liver diseases, reported the Company’s CEO Dr. Pnina Fishman will present at the H.C. Wainwright 22nd Annual Global Investment Conference on Monday, September 14, 2020 at 2:00 pm ET in Room 6 (Press release, Can-Fite BioPharma, SEP 8, 2020, https://ir.canfite.com/news/detail/923/can-fite-to-present-at-h-c-wainwright-22nd-annual-global-investment-conference-on-september-14-2020 [SID1234564730]). This year’s virtual conference will be held from September 14-16, 2020, during which time Dr. Fishman and Can-Fite’s Chief Financial Officer Motti Farbstein will conduct virtual one-on-one meetings with institutional investors.
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!